Results 201 to 210 of about 380,997 (339)

Unexpected complete resolution of intravesical inflammatory myofibroblastic tumor after immunotherapy for melanoma: A case report. [PDF]

open access: yesUrol Case Rep
Lesgart M   +7 more
europepmc   +1 more source

Diagnostic Value of Micro‐Ultrasound in Identifying Local Recurrence After Radical Prostatectomy

open access: yesThe Prostate, Volume 86, Issue 2, Page 189-195, February 2026.
ABSTRACT Purpose The limited resolution of standard transrectal ultrasound (TRUS) has made it difficult to perform biopsies of the prostate bed in cases of suspected local recurrence following radical prostatectomy. The aim of this study was to benchmark the performance of using high resolution micro‐ultrasound (microUS) in place of standard TRUS for ...
Basil Kaufmann   +11 more
wiley   +1 more source

Diagnostic and Prognostic Value of cfDNA Concentration and Fragmentation in Prostate Cancer

open access: yesThe Prostate, Volume 86, Issue 3, Page 338-348, February 15, 2026.
ABSTRACT Objective To evaluate the value of circulating free DNA (cfDNA) in prostate cancer (PCa) by cfDNA assay and analysis of plasma and urinary cfDNA fragmentation to determine the usefulness of this parameter for risk staging and tumor progression monitoring.
Marta Victoria Lorenzo‐Sánchez   +8 more
wiley   +1 more source

Long‐Term Follow‐Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility Trial

open access: yesThe Prostate, Volume 86, Issue 3, Page 365-371, February 15, 2026.
ABSTRACT Introduction Neoadjuvant intense androgen deprivation therapy (ADT) with androgen receptor signaling inhibitors (ARSIs) has shown pathologic complete responses (pCR) in prostate cancer (PCa), but long‐term survival outcomes remain unclear. This study evaluates the durability of response following neoadjuvant ADT plus enzalutamide before robot ...
Braden Millan   +9 more
wiley   +1 more source

Detection of germ cell neoplasia in situ and testicular cancer risk in men with testicular microlithiasis: Real world results through 10 years

open access: yesAndrology, Volume 14, Issue 2, Page 459-465, February 2026.
Abstract Background Guidelines recommend biopsies for men <50 years with testicular microlithiasis and cancer risk factors to rule out germ cell neoplasia in situ. Limited data support this practice. Objectives To clarify the significance of testicular microlithiasis by examining pathological findings in men with testicular microlithiasis.
Karoline Skov Lundager   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy